Baiyunshan (600332.SH): The market application for the chemical raw material drug sulfornetadine toluene sulfonic acid has been approved.

Intelligence Finance APP News, Baiyunshan (600332.SH) announced that its subsidiary Baiyunshan Pharmaceutical Group Co., Ltd. Baiyunshan Chemical Pharmaceutical Factory ("Baiyunshan Chemical Pharmaceutical Factory") has received the "Approval Notice for the Market Application of Tolbutamide Sorafenib" issued by the National Medical Products Administration. Tolbutamide Sorafenib is mainly used for first-line treatment of advanced liver cancer, treatment of advanced kidney cancer, and locally advanced or metastatic thyroid cancer that is ineffective with radioactive iodine therapy.